The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy

Cancer

Volumn 112, Issue 11, 2008, Pages 2401-2408

  Wright, Jonathan L ^a,b   Lin, Daniel W ^a   Porter, Michael P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Lymph node density; Overall survival; Surgical extent; Transitional cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CYSTECTOMY; DEMOGRAPHY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TUMOR CLASSIFICATION; BLADDER TUMOR; CANCER STAGING; DISEASE COURSE; FEMALE; HEALTH SURVEY; INFORMATION PROCESSING; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; CYSTECTOMY; DATA COLLECTION; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROGNOSIS; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 52049106400     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23474     Document Type: Article

References (25)

1. American Cancer Society, Inc. Bladder Cancer Statistics [revised August 8, 2006]. Atlanta, Ga: American Cancer Society, Inc.; 2006.
2. Stein JP, Quek ML, Skinner DG. Lymphadenectomy for invasive bladder cancer. I. Historical perspective and contemporary rationale. BJU Int. 2006;97:227-231.
3. Stein JP, Quek ML, Skinner DG. Lymphadenectomy for invasive bladder cancer. II. Technical aspects and prognostic factors. BJU Int. 2006;97:232-237.
4. Skinner DG. Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol. 1982;128:34-36.
5. Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol. 1998;160(6 pt 1):2015-2019; discussion 2020.
6. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int. 2000;85:817-823.
7. Dretler SP, Ragsdale BD, Leadbetter WF. The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer. J Urol. 1973;109:414-416.
8. Wishnow KI, Johnson DE, Ro JY, Swanson DA, Babaian RJ, von Eschenbach AC. Incidence, extent and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer. J Urol. 1987;137:408-410.
9. Abol-Enein H, El-Baz M, Abd El-Hameed MA, Abdel-Latif M, Ghoneim MA. Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study-a single center experience. J Urol. 2004;172(5 pt 1):1818-1821.
10. Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol. 2004;171:1830-1834.
11. Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003;170:35-41.
12. Lerner SP, Skinner DG, Lieskovsky G, et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol. 1993;149:758-764; discussion764-765.
13. Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004;22:2781-2789.
14. Herr HW. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology. 2003;61:105-108.
15. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol. 2003;169:943-945.
16. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Program Public-Use Data, 1973-2003 (released April 2006; based on the November 2005 submission.). Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2005.
17. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666-675.
18. Herr H, Lee C, Chang S, Lerner S. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a Collaborative Group report. J Urol. 2004;171: 1823-1828; discussion 1827-1828.
19. Kassouf W, Leibovici D, Munsell MF, Dinney CP, Grossman HB, Kamat AM. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol. 2006;176:53-57.
20. Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol. 2003;170:1765-1771.
21. MacMahon S, Collins R. Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies. Lancet. 2001;357:455-462.
22. Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol. 2005;23:2358-2365.
23. Bochner BH, Herr HW, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol. 2001;166:2295-2296.
24. Bochner BH, Cho D, Herr HW, Donat M, Kattan MW, Dalbagni G. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol. 2004;172(4 pt 1):1286-1290.
25. Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer. 2006;107: 2368-2374.